SCHEMBL7873722

SCHEMBL7873722

CN(C(=N)N)C(=O)c1cc2cccc(O)c2[nH]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39
DAO P14920 4/20 0.38
DDO Q99489 2/20 0.38
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
HRH4 Q9H3N8 3/20 0.36
NSD2 O96028 1/20 0.36
FLT3 P36888 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7877769 0.99 GRIN2D (0.38) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7881936 0.86 HRH4 (0.50) MEN1USP2ALDH1A1HPGDKMT2A
SCHEMBL7884356 0.86 NSD2 (0.50) DAODDOALDH1A1HPGDHSD17B10
SCHEMBL7877623 0.85 HRH4 (0.49) DAOMEN1USP2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL7885038 0.85 HRH4 (0.49) MEN1USP2ALDH1A1HPGDKMT2A
Hydrochloric Acid SCHEMBL7873309 0.85 NSD2 (0.49) DAODDOALDH1A1HPGDHSD17B10
Hydrochloric Acid SCHEMBL7878220 0.84 HRH4 (0.48) DAOMEN1USP2ALDH1A1HPGD
SCHEMBL7873932 0.83 HRH4 (0.51) MEN1ALDH1A1HPGDKMT2AKDM4E
Hydrochloric Acid SCHEMBL7881429 0.82 HRH4 (0.50) MEN1ALDH1A1HPGDKMT2AKDM4E
SCHEMBL7879692 0.81 APEX1 (0.61) MEN1HPGDKMT2AHSD17B10KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed